US Patent 10105386 Compositions for the treatment of dry eye
Patent 10105386 was granted and assigned to Allergan, Inc. on October, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+200 characters)
Article
Patent abstract
The present invention relates to ophthalmic compositions and methods useful to treat dry eye, or to diagnose, cure, mitigate, treat, or prevent dry eye syndrome in man or other animals.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Joseph G. Vehige0
Peter A. Simmons0
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
101053860
Date of Patent
October 23, 2018
0Patent Application Number
146017810
Date Filed
January 21, 2015
0Patent Citations Received
Patent Primary Examiner
Edits on 8 Oct, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10105386 Compositions for the treatment of dry eye
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10105386
Date of patent
October 23, 2018
Patent application number
14601781
Date Filed
January 21, 2015
Patent primary examiner
Find more entities like US Patent 10105386 Compositions for the treatment of dry eye
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
